Quick Answer
INTEGRATED BIOPHARMA INC reported Net Income of $808.0 thousand for fiscal year 2025.
INTEGRATED BIOPHARMA INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $808.0K | +621.4% |
| 2024 | $112.0K | +429.4% |
| 2023 | -$34.0K | -100.9% |
| 2022 | $3.84M | -52.1% |
| 2021 | $8.01M | +95.1% |
| 2020 | $4.11M | +143.4% |
| 2019 | $1.69M | +148.6% |
| 2018 | $679.0K | -71.1% |
| 2017 | $2.35M | +144.9% |
| 2016 | $958.0K | +30.3% |
| 2015 | $735.0K | +461.1% |
| 2014 | $131.0K | +40.9% |
| 2013 | $93.0K | +103.4% |
| 2012 | -$2.71M | -18.9% |
| 2011 | -$2.28M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$762.0K | -756.9% | -719.5% |
| September 30, 2025 | $123.0K | -52.5% | -79.9% |
| March 31, 2025 | $611.0K | +114.4% | +426.7% |
| December 31, 2024 | $116.0K | +130.4% | -55.2% |
| September 30, 2024 | $259.0K | +539.0% | -9.1% |
| March 31, 2024 | $285.0K | +1681.2% | +174.6% |
| December 31, 2023 | -$382.0K | -594.5% | -547.5% |
| September 30, 2023 | -$59.0K | -68.6% | -468.8% |
- INTEGRATED BIOPHARMA INC showed an increase of +621.4% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, INTEGRATED BIOPHARMA INC’s net income has grown by 135.4% (from -$2.28 million to $808.0 thousand).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: